DBV Technologies To Present VITESSE Phase 3 Study Of VIASKIN Peanut Patch Data At AAAAI 2026 Annual Meeting
Benzinga Newsdesk 8 months ago
BiotechNewsEventsGeneral
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting